Di(2-ethylhexyl)phthalate leached from medical PVC devices serves as a substrate and inhibitor for the P-glycoprotein

Environmental Toxicology and Pharmacology

Volumn 23, Issue 3, 2007, Pages 272-278

  Kim, Joon Ho ^a,b   Yun, Jisoo ^a   Sohng, Jae Kyung ^c   Cha, Jin Myeong ^d   Choi, Bum Chae ^e   Jeon, Ho Jong ^b   Kim, Sang Hyun ^f   Choi, Cheol Hee ^a,b  

^a Chosun University   (South Korea)

^b Chosun University College of Medicine   (South Korea)

^c SunMoon University   (South Korea)

^d DrugsLife Inc   (South Korea)

^e Creation and Love Women's Hospital   (South Korea)

^f Kyungpook National University School of Medicine   (South Korea)

Author keywords

ATPase; Chemosensitizers; Di(2 ethylhexyl)phthalate; Multidrug resistance; P glycoprotein

Indexed keywords

DI(2 ETHYLHEXYL)PHTHLATE; GLYCOPROTEIN P; MULTIDRUG RESISTANCE PROTEIN; PHTHALIC ACID DERIVATIVE; PHTHALIC ACID DIBUTYL ESTER; PHTHALIC ACID DIETHYL ESTER; POLYVINYLCHLORIDE; UNCLASSIFIED DRUG; VERAPAMIL;

ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DEVICE; ENZYME ACTIVITY; ENZYME SUBSTRATE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; HYDROPHOBICITY; LEACHING; LEUKEMIA CELL LINE; PRIORITY JOURNAL;

EID: 33847219338     PISSN: 13826689     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.etap.2006.11.001     Document Type: Article

References (33)

1. Ambudkar S.V., Lelong I.H., Zhang J., Cardarelli C.O., Gottesman M.M., and Pastan I. Partial purification and reconstitution of the human multidrug-resistance pump: characterization of the drug-stimulatable ATP hydrolysis. Proc. Natl. Acad. Sci. U.S.A. 89 (1992) 8472
2. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72 (1976) 248
3. Choi C.H., Kim H.S., Rha H.S., Jeong J.H., Park Y.H., Min Y.D., Kee K.H., and Lim D.Y. Drug concentration-dependent expression of multidrug resistance-associated protein and P-glycoprotein in the doxorubicin-resistant acute myelogenous leukemia sublines. Mol. Cells 9 (1999) 314
4. Choi C.H., and Ling V. Isolation and characterization of daunorubicin-resistant AML-2 sublines. Mol. Cells 7 (1997) 170
5. Endicott J.A., and Ling V. The biochemistry of P-glycoprotein-mediated multidrug resistance. Annu. Rev. Biochem. 58 (1989) 137
6. Hamada H., and Tsuruo T. Characterization of the ATPase activity of the Mr 170,000 to 180000 membrane glycoprotein (P-glycoprotein) associated with multidrug resistance in K562/ADM cells. Cancer Res. 48 (1988) 4926
7. Kluwe W.M., Haseman J.K., Douglas J.F., and Huff J.E. The carcinogenicity of dietary di(2-ethylhexyl)phthalate (DEHP) in Fischer 344 rats and B6C3F1 mice. J. Toxicol. Environ. Health 10 (1982) 797
8. Loff S., Kabs F., Subotic U., Schaible T., Reinecke F., and Langbein M. Kinetics of diethylhexyl-phthalate extraction from polyvinylchloride-infusion lines. J. Parenter. Enteral. Nutr. 26 (2002) 305
9. Loff S., Subotic U., Reinicke F., Wischmann H., and Brade J. Extraction of di-ethylhexyl-phthalate from perfusion lines of various material, length and brand by lipid emulsions. J. Pediatr. Gastroenterol. Nutr. 39 (2004) 341
10. Maliepaard M., van Gastelen M.A., de Jong L.A., Pluim D., van Waardenburg R.C., Ruevekamp-Helmers M.C., Floot B.G., and Schellens J.H. Overexpression of the BCRP/MXR/ABCP gene in a topotecan-selected ovarian tumor cell line. Cancer Res. 59 (1999) 4559
11. Melnick R.L. Is peroxisome proliferation an obligatory precursor step in the carcinogenicity of di(2-ethylhexyl)phthalate (DEHP)?. Environ. Health Perspect. 109 (2001) 437
12. Miranda S., Vollrath V., Wielandt A.M., Loyola G., Bronfman M., and Chianale J. Overexpression of mdr2 gene by peroxisome proliferators in the mouse liver. J. Hepatol. 26 (1997) 1331
13. Mistry P., Stewart A.J., Dangerfield W., Okiji S., Liddle C., Bootle D., Plumb J.A., Templeton D., and Charlton P. In vitro and in vivo reversal of P-glycoprotein-mediated multidrug resistance by a novel potent modulator, XR9576. Cancer Res. 61 (2001) 749
14. Ozvegy C., Litman T., Szakacs G., Nagy Z., Bates S., Varadi A., and Sarkadi B. Functional characterization of the human multidrug transporter, ABCG2, expressed in insect cells. Biochem. Biophys. Res. Commun. 285 (2001) 111
15. Pieters R., Huismans D.R., Leyva A., and Veerman A.J. Adaptation of the rapid automated tetrazolium dye based (MTT) assay for chemosensitivity testing in childhood leukemia. Cancer Lett. 41 (1988) 323
16. Raderer M., and Scheithauer W. Clinical trials of agents that reverse multidrug resistance. A literature review. Cancer 72 (1993) 3553
17. Riordan J.R., and Ling V. Purification of P-glycoprotein from plasma membrane vesicles of Chinese hamster ovary cell mutants with reduced colchicine permeability. J. Biol. Chem. 254 (1979) 12701
18. Scala S., Akhmed N., Rao U.S., Paull K., Lan L.B., Dickstein B., Lee J.S., Elgemeie G.H., Stein W.D., and Bates S.E. P-glycoprotein substrates and antagonists cluster into two distinct groups. Mol. Pharmacol. 51 (1997) 1024
19. Sharom F.J., Yu X., and Doige C.A. Functional reconstitution of drug transport and ATPase activity in proteoliposomes containing partially purified P-glycoprotein. J. Biol. Chem. 268 (1993) 24197
20. Shepard R.L., Winter M.A., Hsaio S.C., Pearce H.L., Beck W.T., and Dantzig A.H. Effect of modulators on the ATPase activity and vanadate nucleotide trapping of human P-glycoprotein. Biochem. Pharmacol. 56 (1998) 719
21. Seo K.W., Kim K.B., Kim Y.J., Choi J.Y., Lee K.T., and Choi K.S. Comparison of oxidative stress and changes of xenobiotic metabolizing enzymes induced by phthalates in rats. Food Chem. Toxicol. 42 (2004) 107
22. Sikic B.I. Pharmacologic approaches to reversing multidrug resistance. Semin. Hematol. 34 (1997) 40
23. Szakacs G., Ozvegy C., Bakos E., Sarkadi B., and Varadi A. Role of glycine-534 and glycine-1179 of human multidrug resistance protein (MDR1) in drug-mediated control of ATP hydrolysis. Biochem. J. 356 (2001) 71
24. Tickner J.A., Schettler T., Guidotti T., McCally M., and Rossi M. Health risks posed by use of di-2-ethylhexyl phthalate (DEHP) in PVC medical devices: a critical review. Am. J. Ind. Med. 39 (2001) 100
25. Tomatis L. IARC benzene report. Science 218 (1982) 214
26. Tomita I., Nakamura Y., Yagi Y., and Tutikawa K. Teratogenicity/fetotoxicity of DEHP in mice. Environ. Health Perspect. 45 (1982) 71
27. Tsuruo T., Iida H., Tsukagoshi S., and Sakurai Y. Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil. Cancer Res. 41 (1981) 1967
28. Twentyman P.R., Fox N.E., and White D.J. Cyclosporin A and its analogues as modifiers of adriamycin and vincristine resistance in a multi-drug resistant human lung cancer cell line. Br. J. Cancer 56 (1987) 55
29. Vernhet L., Courtois A., Allain N., Payen L., Anger J.P., Guillouzo A., and Fardel O. Overexpression of the multidrug resistance-associated protein (MRP1) in human heavy metal-selected tumor cells. FEBS Lett. 443 (1999) 321
30. Wang E., Casciano C.N., Clement R.P., and Johnson W.W. The farnesyl protein transferase inhibitor SCH66336 is a potent inhibitor of MDR1 product P-glycoprotein. Cancer Res. 61 (2001) 7525
31. Watanabe T., Kokubu N., Charnick S.B., Naito M., Tsuruo T., and Cohen D. Interaction of cyclosporin derivatives with the ATPase activity of human P-glycoprotein. Br. J. Pharmacol. 122 (1997) 241
32. Watanabe T., Uchiyama N., Roninson I.B., Cohen D., and Atadja P. Altered activity of MDR-reversing agents on KB3-1 cells transfected with Gly(185) → Val human P-glycoprotein. Int. J. Oncol. 17 (2000) 579
33. Yoshikawa Y., Hayashi A., Inai M., Matsushita A., Shibata N., and Takada K. Permeability characteristics of endocrine-disrupting chemicals using an in vitro cell culture model, Caco-2 cells. Curr. Drug Metab. 3 (2002) 551